Shilpa Medicare Ltd. News and Updates

Keep track of all breaking news on Shilpa Medicare Ltd. from all sources in a single place.

10 Jul 2025

892.50

-1.48%

Here's why Shilpa Medicare share price is buzzing in trade today; details

Business Standard

Shilpa Medicare shares rose today after the company secured GMP certification from Saudi Arabia's SFDA for its Unit VI facility in Dabaspet, Bengaluru.

Shilpa Medicare Ltd.'s price crossed below 30Day SMA today

Shilpa Medicare Ltd.

26 May 2025

892.50

-1.48%

Shilpa Medicare Results Earnings Call for Q4FY25 & Full Year

Conference Call with Shilpa Medicare Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.

audio

Shilpa Medicare Ltd.

14 Feb 2025, 03:43PM

892.50

-1.48%

Shilpa Medicare Gets 'Buy' Rating As Systematix Initiates Coverage, Sets Target Price Of Rs 857

NDTV Profit

The brokerage believe Shilpa Medicare's differentiated / CRAMS portfolio would help the company to deliver high-teen revenue growth and disproportionate profit expansion.

Shilpa Medicare Ltd. is trading above its 200 day SMA of 781.0

Shilpa Medicare Ltd.

13 Feb 2025

892.50

-1.48%

Here's why Shilpa Medicare share price jumped 8% in trade on February 13

Business Standard

The spike in Shilpa Medicare's stock price came after the company announced the approval of its Investigational New Drug (IND) - Nor Ursodeoxycholic Acid Tablets 500 mg, by CDSCO

Number of FII/FPI investors increased from 114 to 121 in Mar 2025 qtr.

Shilpa Medicare Ltd.

27 Dec 2024

892.50

-1.48%

Shilpa Medicare secures EAEU GMP certification for two Telangana units

Business Line

The shares of Shilpa Medicare Limited were trading at 769.80 up by 4.45 or 0.58 per cent on the NSE

Number of FII/FPI investors increased from 114 to 121 in Mar 2025 qtr.

Shilpa Medicare Ltd.

19 Nov 2024

892.50

-1.48%

Shilpa Medicare rallies 6% on getting API nod from European regulator

Business Standard

Shares of Shilpa Medicare rose 6.23 per cent at Rs 917.20 per share on the BSE in Tuesday's intraday deals

Shilpa Medicare Ltd. is trading below its 30 day SMA of 900.8

Shilpa Medicare Ltd.

14 Nov 2024, 10:48AM

892.50

-1.48%

Shilpa Medicare shares climb 8% after multifold profit growth in Q2FY25

Business Standard

Shilpa Medicare's shares surged as much as 8.45 per cent to hit an intraday high of Rs 894.50 per share

Shilpa Medicare Ltd. is trading below its 30 day SMA of 900.8

Shilpa Medicare Ltd.

16 Oct 2024

892.50

-1.48%

Shilpa Medicare's US Customer Gets Fast Track Approval For Glioblastoma Drug

NDTV Profit

Shilpa Medicare's drug is presently undergoing a Phase 1A clinical trial to test its safety and how well it is tolerated in various solid tumors, including GBM.

Shilpa Medicare Ltd. has gained 39.47% in the last 3 Months

Shilpa Medicare Ltd.

04 Oct 2024

892.50

-1.48%

Shilpa Medicare shares rise 3% on receiving CEP for Desmopressin; details

Business Standard

Shilpa Medicare share price surged after the company said that its arm, Shilpa Pharma Lifesciences, has received certificate of suitability (CEP) from EDQM for API, Desmopressin

Shilpa Medicare Ltd.'s price crossed below 30Day SMA today

Shilpa Medicare Ltd.

16 Sep 2024

892.50

-1.48%

This pharma stock has zoomed 179% so far in CY24; Antique sees more upside

Business Standard

Shares of Shilpa Medicare hit a new high of Rs 922, gaining 4% in Monday's intra-day trade after Antique Stock Broking initiate coverage on the stock with a BUY rating and a target price of Rs 1,300.

Shilpa Medicare Ltd. has gained 35.51% in the last 1 Year

Is Shilpa Medicare Ltd. worth buying?

246 Votes:

Buy 78.86%

Sell 11.79%

Hold 9.35%

60.81% Gain from 52W Low

Shilpa Medicare Ltd. News and Updates

Keep track of all breaking news on Shilpa Medicare Ltd. from all sources in a single place.